
Buchanan Ingersoll & Rooney’s Dae Lee, PharmD, Esq, CPBS, and Lucas Morgan, Esq, explore the evolving world of PBMs within the supply chain as well as the role of state boards of pharmacy.

Brian Nowosielski is an editor at Drug Topics®. He graduated in 2021 from Temple University with a degree in journalism and an English minor. He's been an associate with MJH Life Sciences since February 2024 and has a background in digital and print content for the pharmacy and travel industries.

Buchanan Ingersoll & Rooney’s Dae Lee, PharmD, Esq, CPBS, and Lucas Morgan, Esq, explore the evolving world of PBMs within the supply chain as well as the role of state boards of pharmacy.

In part 2, ASCP’s senior policy expert James Lewis breaks down the MTF system and how it is impacting the thousands of pharmacies that dispense Medicare-covered drugs.

Medical organizations challenge the government's revised childhood vaccine schedule, urging Congress for immediate oversight and action to protect public health.

Representatives from the American Society of Consultant Pharmacists joined Drug Topics to discuss the day 1 reality of the Medicare Drug Price Negotiation Program.

President of the Pennsylvania Pharmacists Association, John DeJames, shared his organization’s goals for advancing the pharmacy profession.

Focused on lowering costs and saving patients money, the plan is focused on drug prices, insurance premiums, and some of health care’s largest companies.

To celebrate National Pharmacist Day, regonized every year on January 12, Meagan Brown, PharmD, BCACP, discussed the current state of nationally recognizing pharmacists as clinical providers.

This marks the disease’s very first treatment option for pediatric patients looking to manage Menkes and its symptoms.

The current understanding regarding artificial intelligence (AI) in pharmacy curricula is necessary to equip future pharmacists with advanced technological knowledge.

Mark Ciarlone, PharmD, business development manager at Liberty Software, discusses pharmacy management systems that drive results.

Outcomes’ Jon Carlson and Nic Bernabe discuss PillCount, Rx30, and the technology making a difference behind community pharmacy counters—among many other pharmacy solutions.

In part 3, Meagan Brown, PharmD, BCACP, explored sentiments of pharmacist’s provider status among other health care professionals.

A group of researchers conducts 3 focus groups centered on community pharmacies in Colorado and Utah and the impact of their closures.

Meagan Brown, PharmD, BCACP, discusses the nuances of pharmacists’ provider status and its evolution within the greater health care community.

This episode explores the unique nuance between striving for goals in the pharmacy profession and focusing on personal growth as a long-term effort.

Addressing the lack of evidence regarding pharmacists’ roles as immunization authorities on infant respiratory syncytial virus (RSV) vaccines.

Meagan Brown, PharmD, BCACP, discusses her career journey in various pharmacy roles during National Pharmacist Day, January 12.

Following approval in 2023, researchers address lessons learned from the coalition- and movement-driven efforts to approve the first OTC oral contraceptive pill.

Pharmacists received surveys to quantify their usage of collaborative practice agreements among community pharmacies in Ohio.

From gaps in care to formulary challenges, Susan Thomas, RN, explains how her independent PBM is working with pharmacists to improve women’s health outcomes.

Pharmacy staff's confidence in the Senior Safe's effectiveness was the key factor leading to the success of managing OTC medication misuse among older adults.

US adults were surveyed about their understanding of shared clinical decision-making following the HHS overhaul of childhood vaccines.

Episode 6 explores what pharmacists in the diabetes space need to know about outcomes data, safety, and when to escalate LDL-lowering therapy.

In part 3 of our interview with Susan Thomas, RN, she focused on the pharmacist’s role in her organization’s creation of a newly launched women’s health benefit program.

The administration announces back-to-back approvals for oral therapies used to treat uncomplicated urogenital gonorrhea.

Susan Thomas, RN, CCO at LucyRx, explained the unique offerings from a newly introduced women’s health benefit program launched on January 1, 2026.

Although several vaccines are still being recommended, a variety of those protecting against respiratory viruses and other diseases have been narrowed on child vaccine schedules.

The company announces that the pill is now available at over 70,000 pharmacies across the country.

Susan Thomas, RN, joined Drug Topics to discuss current gaps in women’s health and how pharmacists are stepping in to counsel in this space more than ever before.

As social media’s growth seemingly has no end in sight, pharmacists must be conscious of its potential risks and benefits when using these platforms for either personal or professional use.